News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
The Prognostic Value of Lymphocyte Subset Levels in HCC by Si-Tong Wang et al. – Hepatoma Research
medicinetoday.com
Dec 26, 2024, 15:52

The Prognostic Value of Lymphocyte Subset Levels in HCC by Si-Tong Wang et al. – Hepatoma Research

A recent paper by Si-Tong Wang, Radiation Oncologist at Zhongshan Hospital, published in Hepatoma Research, was mentioned by Hepatoma Research on X:

“New Original Article Highlight!

Discover the Prognostic Value of Lymphocyte Subset Levels in Hepatocellular Carcinoma following conventionally fractionated vs. stereotactic body radiotherapy.”

“Prognostic value of lymphocyte subset levels in hepatocellular carcinoma following conventionally fractionated vs. stereotactic body radiotherapy”

Authors: Si-Tong Wang, Yi-Xing Chen, Yu-Nan Gao, Ping Yang, Qian-Qian Zhao, Zhao-Chong Zeng, Yuan Zhuang.

The Prognostic Value of Lymphocyte Subset Levels in HCC by Si-Tong Wang et al. - Hepatoma Research

cancer HCC hepatocellular carcinoma Hepatoma Research OncoDaily Oncology Ping Yang Qian-Qian Zhao Si-Tong Wang Yi-Xing Chen Yu-Nan Gao Yuan Zhuang Zhao-Chong Zeng
Special Coverage
Science
Dec 26, 2024, 15:52
The Prognostic Value of Lymphocyte Subset Levels in HCC by Si-Tong Wang et al. - Hepatoma Research
Insight
Dec 26, 2024, 15:50
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Science
Dec 26, 2024, 15:46
Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. - JITC
Insight
Dec 26, 2024, 15:33
Tumors in Black patients with cancer are more likely to exhibit whole-genome duplication - Yale School of Medicine
Science
Dec 26, 2024, 15:25
CT-Based Body Composition and Frailty as Predictors of Survival Among Older Adults With GI Malignancies
Insight
Dec 26, 2024, 15:22
Ilias Houda: Our EORTC survey on resectability of stage III NSCLC
Positive
Dec 26, 2024, 15:12
Celebrating the Holiday Magic with Medical Community
Insight
Dec 26, 2024, 15:10
Eliminating cancer with nivolumab and the chemotherapy regimen AVD - NCI
Insight
Dec 26, 2024, 15:06
Julian Downward: Compounds that block the interaction of RAS proteins with PI3-kinase
Science
Dec 26, 2024, 15:03
Myeloma Paper of the Day, December 26th, suggested by Robert Orlowski
Insight
Dec 26, 2024, 15:03
Amol Akhade: Adjuvant nivolumab in Muscle-Invasive Urothelial Carcinoma
Blog
Dec 26, 2024, 14:55
Jonathan Govette: Wishing everyone a joyful holiday season from Oatmeal Health